Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region

Infection and Immunity

Volumn 80, Issue 3, 2012, Pages 1209-1221

  Cuccui, Jon ^a   Milne, Timothy S ^b   Harmer, Nicholas ^c   George, Alison J ^b   Harding, Sarah V ^b   Dean, Rachel E ^b   Scott, Andrew E ^b   Mitali, Sarkar Tyson ^b   Wren, Brendan W ^a   Titball, Richard W ^c   Prior, Joann L ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^c UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLTRANSFERASE; POLYSACCHARIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BIOINFORMATICS; BIOSYNTHESIS; BURKHOLDERIA PSEUDOMALLEI; CHROMOSOME 1; CONTROLLED STUDY; GENETIC CODE; IMMUNOFLUORESCENCE; LIPOGENESIS; MOUSE; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SURVIVAL; SURVIVAL TIME; WESTERN BLOTTING;

ANIMALS; BACTERIAL VACCINES; BIOSYNTHETIC PATHWAYS; BLOTTING, WESTERN; BURKHOLDERIA PSEUDOMALLEI; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKOUT TECHNIQUES; GENETIC LOCI; MELIOIDOSIS; MICE; MICE, INBRED BALB C; MULTIGENE FAMILY; POLYSACCHARIDES, BACTERIAL; VACCINES, ATTENUATED; VIRULENCE; VIRULENCE FACTORS;

EID: 84857667548     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05805-11     Document Type: Article

References (43)

1. Atkins T, et al. 2002. Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. J. Med. Microbiol. 51:539-547.
2. Atkins T, et al. 2002. A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect. Immun. 70:5290-5294.
3. Bentley SD, et al. 2006. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2:e31.
4. Brook MD, Currie B, Desmarchelier PM. 1997. Isolation and identification of Burkholderia pseudomallei from soil using selective culture techniques and the polymerase chain reaction. J. Appl. Microbiol. 82:589-596.
5. Cuccui J, et al. 2007. Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis. Infect. Immun. 75:1186-1195.
6. Currie BJ, Fisher DA, Anstey NM, Jacups SP. 2000. Melioidosis: acute and chronic disease, relapse and re-activation. Trans. R. Soc. Trop. Med. Hyg. 94:301-304.
7. Currie BJ, et al. 2000. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin. Infect. Dis. 31:981-986.
8. Currie BJ, et al. 2004. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop. Med. Int. Health 9:1167-1174.
9. Dance DA. 1991. Melioidosis: the tip of the iceberg? Clin. Microbiol. Rev. 4:52-60.
10. Dance DA. 2000. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop. 74:159-168.
11. Dance DA. 2000. Melioidosis as an emerging global problem. Acta Trop. 74:115-119.
12. de Lorenzo V, Herrero M, Jakubzik U, Timmis KN. 1990. Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria. J. Bacteriol. 172:6568-6572.
13. DeShazer D, Waag DM, Fritz DL, Woods DE. 2001. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb. Pathog. 30:253-269.
14. Ellis J. 2000. Antibody detection of Burkholderia pseudomallei and Burkholderia mallei. Ph.D. dissertation. Aston University, Birmingham, United Kingdom.
15. Essex-Lopresti AE, et al. 2005. A type IV pilin, PilA, contributes to adherence of Burkholderia pseudomallei and virulence in vivo. Infect. Immun. 73:1260-1264.
16. Harmer NJ. 2010. The structure of sedoheptulose-7-phosphate isomerase from Burkholderia pseudomallei reveals a zinc binding site at the heart of the active site. J. Mol. Biol. 400:379-392.
17. Holden MTG, et al. 2004. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc. Natl. Acad. Sci. U. S. A. 101:14240-14245.
18. Howe C, Sampath A, Spotnitz M. 1971. The pseudomallei group: a review. J. Infect. Dis. 124:598-606.
19. Jones SM, Ellis JF, Russell P, Griffin KF, Oyston PC. 2002. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J. Med. Microbiol. 51:1055-1062.
20. Knirel YA, et al. 1992. Structure of the polysaccharide chains of Pseudomonas pseudomallei lipopolysaccharides. Carbohydr. Res. 233:185-193.
21. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
22. Logue CA, Peak IR, Beacham IR. 2009. Facile construction of unmarked deletion mutants in Burkholderia pseudomallei using sacB counterselection in sucrose-resistant and sucrose-sensitive isolates. J. Microbiol. Methods 76:320-323.
23. Nelson M, et al. 2004. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J. Med. Microbiol. 53:1177-1182.
24. Pacinelli E, Wang L, Reeves PR. 2002. Relationship of Yersinia pseudotuberculosis O antigens IA, IIA, and IVB: the IIA gene cluster was derived from that of IVB. Infect. Immun. 70:3271-3276.
25. Parthasarathy N, DeShazer D, England M, Waag DM. 2006. Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies. Diagn. Microbiol. Infect. Dis. 56:329-332.
26. Pavelka MS, Jr, Wright LF, Silver RP. 1991. Identification of two genes, kpsM and kpsT, in region 3 of the polysialic acid gene cluster of Escherichia coli K1. J. Bacteriol. 173:4603-4610.
27. Perry MB, MacLean LL, Schollaardt T, Bryan LE, Ho M. 1995. Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect. Immun. 63:3348-3352.
28. Reckseidler SL, DeShazer D, Sokol PA, Woods DE. 2001. Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence factor. Infect. Immun. 69:34-44.
29. Reckseidler-Zenteno SL, DeVinney R, Woods DE. 2005. The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect. Immun. 73:1106-1115.
30. Roberts IS. 1996. The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu. Rev. Microbiol. 50:285-315.
31. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. 2002. Public health assessment of potential biological terrorism agents. Emerg. Infect. Dis. 8:225-230.
32. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Sarkar-Tyson M, et al. 2007. Polysaccharides and virulence of Burkholderia pseudomallei. J. Med. Microbiol. 56:1005-1010.
34. Sim BM, et al. 2010. Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates. Genome Biol. 11:R89.
35. Stevens MP, et al. 2004. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology 150:2669-2676.
36. Ulrich RL, Amemiya K, Waag DM, Roy CJ, DeShazer D. 2005. Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice. Vaccine 23:1986-1992.
37. Warawa JM, Long D, Rosenke R, Gardner D, Gherardini FC. 2009. Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis. Infect. Immun. 77:5252-5261.
38. West TE, et al. 2010. Pathogenicity of high-dose enteral inoculation of Burkholderia pseudomallei to mice. Am. J. Trop. Med. Hyg. 83:1066-1069.
39. Whitfield C. 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 75:39-68.
40. Whitfield C, Keenleyside WJ. 1995. Regulation of expression of group IA capsular polysaccharides in Escherichia coli and related extracellular polysaccharides in other bacteria. J. Ind. Microbiol. 15:361-371.
41. Wikraiphat C, et al. 2009. Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants. FEMS Immunol. Med. Microbiol. 56:253-259.
42. Wuthiekanun V, Peacock SJ. 2006. Management of melioidosis. Expert Rev. Anti Infect. Ther. 4:445-455.
43. Yee KC, Lee MK, Chua CT, Puthucheary SD. 1988. Melioidosis, the great mimicker: a report of 10 cases from Malaysia. J. Trop. Med. Hyg. 91:249-254.